FASLG and autoimmune disease: Indeed, we have demonstrated previously the ability of MRL/lpr T cells overexpressing FasL to induce non-antigen-specific killing in vivo[11], [12], and we have also shown that in vivo elimination of these FasL+ T cells using arsenic trioxide (As2O3) administration cured or prevented autoimmune diseases [13].